Literature DB >> 8678447

Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.

I M Modlin1, G P Lawton, K Miu, M Kidd, E A Luque, A Sandor, L H Tang.   

Abstract

The genesis of human gastric carcinoma is ill understood but is invariably related to achlorhydria. Gastrin secretion is negatively regulated by luminal acid and hypergastrinaemia is thus associated with low acid states which may be natural (atrophic gastritis) or owing to acid inhibitory therapy. Apart from its acid secretory activity, gastrin is trophic to the mucosa, via stimulation of the fundic enterochromaffin-like (ECL) cells to secrete histamine. In conditions of elevated gastrin levels, ECL cell hyperplasia and even neoplasia have been noted. The relationship between low acid, hypergastrinaemia, ECL cell hyperplasia, and neoplasia may be of relevance since ECL cells secrete histamine and TGF alpha which are both recognised mitogens. We studied the rodent mastomys, which spontaneously develop gastric carcinoid tumours, which can be generated in 4 months under conditions of drug-induced acid inhibition and inhibited by octreotide administration. A pure (90-95%) cell preparation was used to evaluate ECL cell physiology and trophic regulation. A gastrin/CCKB receptor responsible for histamine secretion and DNA synthesis was identified, cloned and sequenced. Octreotide lowers plasma gastrin levels, decreases ECL cell neoplasia and, in vitro, inhibits ECL cell DNA synthesis. H1 receptor antagonists inhibited DNA synthesis in vitro and ECL neoplasia in vivo without altering gastrin levels. Hypergastrinaemia increased TGF alpha/EGF receptor and TGF alpha production and TGF alpha massively stimulated ECL cell DNA synthesis. Since ECL cells produce both histamine and TGF alpha and regulate parietal cells which produce TGF alpha, it is possible that achlorhydria-generated ECL cell dysfunction may play an initiative role in the pathobiology of gastric adenocarcinoma. The long-term clinical consequences of drug-induced sustained acid inhibition are worthy of further consideration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678447      PMCID: PMC2502546     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  18 in total

1.  Production and auto-induction of transforming growth factor-alpha in human keratinocytes.

Authors:  R J Coffey; R Derynck; J N Wilcox; T S Bringman; A S Goustin; H L Moses; M R Pittelkow
Journal:  Nature       Date:  1987 Aug 27-Sep 2       Impact factor: 49.962

2.  Quantitative electron microscopy of endocrine cells in oxyntic mucosa of normal human stomach.

Authors:  T D'Adda; A Bertelé; F P Pilato; C Bordi
Journal:  Cell Tissue Res       Date:  1989-01       Impact factor: 5.249

3.  Characteristics of the spontaneous gastric endocrine tumor of mastomys.

Authors:  I M Modlin; K A Zucker; M J Zdon; J Sussman; T E Adrian
Journal:  J Surg Res       Date:  1988-03       Impact factor: 2.192

4.  Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy.

Authors:  B I Hirschowitz; J Griffith; D Pellegrin; O W Cummings
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

5.  Endocrine cells in the human oxyntic mucosa. A histochemical study.

Authors:  M Simonsson; S Eriksson; R Håkanson; T Lind; H Lönroth; L Lundell; D T O'Connor; F Sundler
Journal:  Scand J Gastroenterol       Date:  1988-11       Impact factor: 2.423

6.  Stimulation of in vivo tumor growth and phorbol ester-induced inflammation by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine HCl, a potent ligand for intracellular histamine receptors.

Authors:  L J Brandes; W A Beecroft; G R Hogg
Journal:  Biochem Biophys Res Commun       Date:  1991-09-30       Impact factor: 3.575

7.  Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample.

Authors:  P Sipponen; M Kekki; M Siurala
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860

8.  Histamine as an intermediate growth factor in genesis of gastric ECLomas associated with hypergastrinemia in mastomys.

Authors:  I M Modlin; R R Kumar; C J Soroka; H Ahlman; O Nilsson; J R Goldenring
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

9.  Significance of gastric endocrine tumor and age-related gut peptide alterations in Mastomys.

Authors:  A J Bilchik; O Nilsson; I M Modlin; K A Zucker; T E Adrian
Journal:  Regul Pept       Date:  1990-02-04

Review 10.  Ulcer epidemiology: an overview and proposed research framework.

Authors:  J H Kurata
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

View more
  3 in total

1.  Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.

Authors:  Kurt Borch; Bo Ahrén; Håkan Ahlman; Sture Falkmer; Göran Granérus; Lars Grimelius
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

2.  Metastatic type 1 gastric carcinoid: a real threat or just a myth?

Authors:  Simona Grozinsky-Glasberg; Dimitrios Thomas; Jonathan R Strosberg; Ulrich-Frank Pape; Stephan Felder; Apostolos V Tsolakis; Krystallenia I Alexandraki; Merav Fraenkel; Leonard Saiegh; Petachia Reissman; Gregory Kaltsas; David J Gross
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 3.  Histamine metabolism of gastric carcinoids in Mastomys natalensis.

Authors:  L Kölby; B Wängberg; H Ahlman; I M Modlin; O Nilsson
Journal:  Yale J Biol Med       Date:  1998 May-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.